Pages that link to "Q21261310"

The following pages link to In vitro and in vivo characterization of highly purified human mesothelioma derived cells (Q21261310):

Displaying 14 items.

• A Subset of Malignant Mesothelioma Tumors Retain Osteogenic Potential (Q28394868) (← links)
• Should EMT of Cancer Cells Be Understood as Epithelial-Myeloid Transition? (Q34402141) (← links)
• Long non coding RNAs (lncRNAs) are dysregulated in Malignant Pleural Mesothelioma (MPM). (Q34970431) (← links)
• NAC, tiron and trolox impair survival of cell cultures containing glioblastoma tumorigenic initiating cells by inhibition of cell cycle progression. (Q35108652) (← links)
• Preclinical studies identify novel targeted pharmacological strategies for treatment of human malignant pleural mesothelioma (Q36159154) (← links)
• Addressing the Inflammatory Response to Clinically Relevant Polymers by Manipulating the Host Response Using ITIM Domain-Containing Receptors (Q38364218) (← links)
• Multiple roles of CD90 in cancer. (Q38805813) (← links)
• Establishment of a cell line from a Japanese patient useful for generating an in vivo model of malignant pleural mesothelioma (Q39612474) (← links)
• A potential therapeutic strategy for malignant mesothelioma with gene medicine (Q41846143) (← links)
• The inhibition of FGF receptor 1 activity mediates sorafenib antiproliferative effects in human malignant pleural mesothelioma tumor-initiating cells (Q42038363) (← links)
• The "don't eat me" signal CD47 is a novel diagnostic biomarker and potential therapeutic target for diffuse malignant mesothelioma (Q47133389) (← links)
• Development of anti-human mesothelin-targeted chimeric antigen receptor (CAR) messenger RNA (mRNA)-transfected peripheral blood lymphocytes (CARMA-hMeso) for ovarian cancer therapy (Q50025535) (← links)
• Live-Cell Mesothelioma Biobank to Explore Mechanisms of Tumor Progression. (Q52661560) (← links)
• Experimental Evidence and Clinical Implications of Pituitary Adenoma Stem Cells (Q90176430) (← links)